AAIC 2025 Abstract
Lecanemab Eligibility in Korean Memory Clinic and Research Populations: A Retrospective Analysis
Study in peoplePopulations
Abstract
Background: Despite lecanemab's approval in South Korea in May 2024, limited information is available for the proportion of patients who are eligible for lecanemab treatment in Korea.
